Georgeanna J Huang, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1000 Newbury Rd Ste 165, Thousand Oaks, CA 91320 Phone: 805-496-9976 Fax: 805-496-9970 |
Dr. Roee Elan Rubinstein, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 400 S Reino Rd Ste 200, Thousand Oaks, CA 91320 Phone: 805-379-9353 Fax: 805-379-4494 |
Edward O Terino, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 327 S Moorpark Rd, Thousand Oaks, CA 91361 Phone: 805-495-1043 |
Dr. Tjerk F Bury, MD Plastic Surgery - Surgery of the Hand Medicare: Not Enrolled in Medicare Practice Location: 351 Rolling Oaks Dr Ste 203, Thousand Oaks, CA 91361 Phone: 805-777-7333 Fax: 805-777-7330 |
Brian Howard Slywka, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 351 Rolling Oaks Dr, Suite 101, Thousand Oaks, CA 91361 Phone: 805-497-1105 Fax: 805-497-6144 |
Dr. Kouros Azar, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 425 Haaland Dr Ste 200, Thousand Oaks, CA 91361 Phone: 805-373-7073 Fax: 805-373-1116 |
Richard M Hodnett, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 375 Rolling Oaks Dr, Suite 110, Thousand Oaks, CA 91361 Phone: 805-777-8956 |
Dr. Christopher Costanzo, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 2190 Lynn Rd, Ste 380, Thousand Oaks, CA 91360 Phone: 805-373-9919 |
Michael C Ciano, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2190 Lynn Rd Ste 310, Thousand Oaks, CA 91360 Phone: 805-497-8411 Fax: 805-496-5632 |
News Archive
A new article published today in The Lancet Oncology shows 39 percent of large B cell lymphoma patients treated with the chimeric antigen receptor T-cell therapy Yescarta remained in remission more than two years following therapy, and more than half of the patients treated remain alive.
Under the Foundation of Greater Montreal's Community Grants Program, the Montreal Chapter of the Multiple Sclerosis Society of Canada will receive $10,000, which will ensure the continuity of its program of physical activities adapted for people with multiple sclerosis.
Most research on Lou Gehrig's disease therapeutics has been based on the assumption that its two forms (sporadic and hereditary) are similar in their underlying cause.
Researchers from TARA Biosystems, Inc. and GlaxoSmithKline today published data demonstrating that TARA's engineered heart-on-a-chip system replicated drug responses found in adult humans.
Vivakor, Inc. today announced the launch of its new website promoting its remarkable VivaThermic Vial at www.vivathermic.com.
› Verified 4 days ago